Windtree Therapeutics

Windtree Therapeutics is developing multiple late-stage therapies for acute cardiovascular and acute pulmonary disorders.

photo of the wind blowing a tree into a 90-degree angle toward the left
Biotech

Cash-strapped Windtree seeks biotechs with FDA-approved products

Despite its dwindling cash reserves, Windtree has announced a bold new strategy—trying to acquire small biotechs with FDA-approved products.
James Waldron Jan 9, 2025 4:44am
photo of a paraglider in the foreground with the alps in the background

Flagship-backed biotechs name new leaders—Chutes & Ladders

Nov 15, 2024 8:30am
photo of the wind blowing a tree into a 90-degree angle toward the left

Windtree's shock med raises blood pressure in latest phase 2 win

Sep 25, 2024 9:59am
photo of the wind blowing a tree into a 90-degree angle toward the left

Despite cash infusion, Windtree still needs rescue within a year

Aug 21, 2024 5:45am
wind vane weather wind speed direction change airport

Windtree's search for help shifts to full company sale

Jan 31, 2024 10:35am
photo of the wind blowing a tree into a 90-degree angle toward the left

Windtree hands over more licensing rights to Lee’s Pharma

Jan 17, 2024 9:29am